Clinical Considerations for FMT for Recurrent Clostridioides Difficile


With fecal microbiota transplants (FMT) becoming a potential emerging therapy for these patients, here are some aspects to consider when treating.

Video Highlights

1:14 Sahil Khanna, MBBA, MS

4:29 Glenn Tillotson, PhD, FIDSA, FCCP

5:34 Anurag Malani, MD

Welcome to our series, 1 Big Question, which asks 1 question to the medical community and we get their feedback on an important infectious disease topic.

In this episode, our 1 Big Question is: One of the more interesting treatment areas within C diff is fecal microbiota transplants. What is your take on this potentially being used as a therapy in patients with recurrent c diff?

We interviewed, Sahil Khanna, MBBS, MS, is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Glenn Tillotson, PhD, FIDSA, FCCP, GST Micro LLC, and Anurag Malani, MD, infectious diseases specialist, St. Joseph Hospital, and a fellow of Infectious Diseases Society of America (IDSA).

Check out our video to hear their insights.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.